Clinical Trial Update: Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update of a novel swine influenza virus vaccine in Japanese pediatric subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Swine Influenza

Drugs mentioned

• Novel Swine Influenza Virus Vaccine

Snippet

Sponsor: Novartis Vaccines | Conditions: Swine-Origin Influenza A H1N1 Virus | Phase 2, Phase 3 | Status: COMPLETED